Zentalis Pharmaceuticals (ZNTL) Restructuring Costs (2025)
Zentalis Pharmaceuticals' (ZNTL) quarterly Restructuring Costs came in at $7.8 million in Q1 2025.
Zentalis Pharmaceuticals (ZNTL) Restructuring Costs (2025) Analysis & Trends
Zentalis Pharmaceuticals' Restructuring Costs history runs 1 years deep, the most recent figure standing at $7.8 million for Q1 2025.
- On a quarterly basis, Restructuring Costs changed N/A year-over-year to $7.8 million in Q1 2025; TTM through Dec 2025 was $7.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.8 million, changed N/A from the prior year.
- Restructuring Costs steadied at $7.8 million in Q1 2025 per ZNTL's latest filing.
- Across five years, Restructuring Costs topped out at $7.8 million in Q1 2025 and bottomed at $7.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Zentalis Pharmaceuticals | 302.14 Mn | 302.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 7.80 Mn |